- Home
- GDYN vs OVID Comparison
GDYN vs OVID Comparison
Compare GDYN & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDYN | OVID |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 509.3M | 522.6M |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | GDYN | OVID |
|---|---|---|
| Price | $5.40 | $2.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $10.67 | $4.60 |
| AVG Volume (30 Days) | 2.1M | ★ 2.4M |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | 3.90 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $111,283,000.00 | $7,252,000.00 |
| Revenue This Year | $10.16 | N/A |
| Revenue Next Year | $10.84 | $19.34 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1181.27 |
| 52 Week Low | $5.11 | $0.30 |
| 52 Week High | $12.86 | $3.11 |
Technical Indicators
Market Signals| Indicator | GDYN | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 34.98 | 53.11 |
| Support Level | $5.27 | $2.25 |
| Resistance Level | $6.11 | $2.74 |
| Average True Range (ATR) | 0.41 | 0.17 |
| MACD | -0.14 | 0.02 |
| Stochastic Oscillator | 18.21 | 77.17 |
Price Performance
Historical ComparisonAbout GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.